NR1I2 and colitis: Those anti-colitis effects were accompanied by decreases in the expression or secretion of pro-inflammatory cytokines such as interleukin-6, interleukin-1β (IL-1β), or tumor necrosis factor-alpha, suggesting that PXR interferes with the nuclear factor κB (NF-κB) [52].